ITEMS IN AFP WITH KEYWORD:
Nov 1, 2012 Issue
AACE Releases Guidelines for Menopausal Hormone Therapy [Practice Guidelines]
Menopause is diagnosed in women who have not had menses for one year. The American Association of Clinical Endocrinologists (AACE) convened a task force to review available evidence on therapies for menopausal symptoms. The task force's guidelines include recommendations for prescribing menopausal h...
Feb 1, 2012 Issue
Exercise for Treatment of the Vasomotor Symptoms of Menopause [Cochrane for Clinicians]
Although menopausal women who exercise are less likely to report vasomotor symptoms than those who do not, there is insufficient evidence that counseling women to exercise is more effective than no treatment or hormone therapy for vasomotor symptoms of menopause.
Jul 1, 2011 Issue
Hormone Therapy for Postmenopausal Women with Urinary Incontinence [FPIN's Clinical Inquiries]
Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence.
The results of recent large clinical trials have led physicians and patients to question the safety of menopausal hormone therapy. In the past, physicians prescribed hormone therapy in an attempt to improve overall health and prevent cardiac disease. Hormone therapy appears to increase the risk of b...
Soybeans contain all of the essential amino acids necessary for human nutrition and have been grown and harvested for thousands of years. Populations with diets high in soy protein and low in animal protein have lower risks of prostate and breast cancers than other populations. Increasing dietary wh...
Menopause is the permanent cessation of menstruation resulting from the loss of ovarian and follicular activity. It usually occurs when women reach their early 50s. Vasomotor symptoms and vaginal dryness are frequently reported during menopause. Estrogen is the most effective treatment for managemen...
What are the effects of treatments to prevent fractures in postmenopausal women?
The North American Menopause Society (NAMS) has released an updated position statement on the use of estrogen therapy (ET) and combined estrogen-progestogen therapy (EPT) in perimenopausal and postmenopausal women, based on the latest evidence on the risks and benefits associated with the use of ET and EPT.
Nov 1, 2006 Issue
Hormone Therapy in Postmenopausal and Perimenopausal Women [Cochrane for Clinicians]
Relatively healthy women taking combined continuous hormone therapy have higher risks of myocardial infarction and venous thromboembolism after one year, stroke after three years, and breast cancer after five years. In women who take hormone therapy continuously for five years, there is a lower inci...
Numerous reports in the medical literature and popular media have discussed the effectiveness of various nonhormonal agents in reducing menopausal hot flash symptoms. Data for these therapies are limited, and most of the studies have been conducted in women with a history of breast cancer. Selective...